Freedom of information (FOI) releases from UK Research and Innovation (UKRI)

This is a disclosure log of UK Research and Innovation's responses to freedom of information (FOI) or environmental information regulations (EIR) requests that might be of wider public interest.

If you can't find the information you're looking for, you can make a new FOI request.

Filters

Clear filters
  • Keywords filters

  • Year filters

  • Month filters

1,368 disclosures

  1. Request Received: 20 February 2026

    Please could you provide the date on which the Innovate UK grant applications were submitted for the projects involving the following organisations:

    • James Mae Water

    • Aspcold Manufacturing

    If more than one application exists involving these organisations, I would be grateful if you could provide the application date(s) for each relevant grant, along with the grant title or competition name. I do not require any commercially sensitive information beyond the application submission date.

    Published: 29 April 2026

  2. Request Received: 22 February 2026

    I contacted the author of this published paper (https://nora.nerc.ac.uk/id/eprint/12280) requesting a copy of the data many years back and it was refused.

    It states in the paper:

     "compilation of isotopic datasets by the British Geological Survey (BGS) over the past 25 years combined with (relatively scarce) published studies by other researchers makes it possible for the present paper to attempt a synthesis.”

    And in the acknowledgements:

     "Most of the groundwater data considered in this paper have come from studies carried out by staff of the British Geological Survey over the past quarter-century.”

    Could the BGS please provide all the oxygen and hydrogen isotope data for groundwater and surface water that the BGS contain?

    Published: 29 April 2026

  3. Request received: 09 March 2026

    Please provide copies of all formal written Quarterly Reports submitted to Innovate UK to date under the AI Skills Hub (UKRI-3797) contract, as required under section 5 (Reporting Requirements) of the specification.

    Published: 29 April 2026

  4. Request received: 30/03/2026

    Under the Freedom of Information Act, can you please provide:

    1) the most recent mid-point review for:
    a) Administrative Data Research UK (to the extent that MRC holds this information about ADRUK),
    b) Data and Analytics Research Environments UK programme,
    c) Health Data Research UK,
    d) Population Research UK,
    e) UK Biobank,
    f) UK Health Data Research Alliance,

    2) the response of each organisation (a-f) to the findings of their review.

    Published: 28 April 2026

  5. Request Received: 18 February 2026

    I would like to make a freedom of information request about the costs of the AI training program that has been announced in the news today, specifically this announcement: https://www.gov.uk/government/news/free-ai-training-for-all-as-government-and-industry-programme-expands-to-provide-10-million-workers-with-key-ai-skills-by-2030

    I understand that the cost to end users will for the most part be zero. I would like to know the cost to the taxpayer.

    Please could you tell me how much the government has spent on setting up this scheme, and what the budget is for annual running costs.

    I note that the scheme is delivered in partnership with tech companies such as Microsoft and Google. If they have provided contributions to the program at less than a fair market rate, then please tell me what those contributions were, how much they actually charged for them, how much a fair market rate would have been, and what they have been given or promised in return for delivering their services below a market rate.

    Please could you also tell me what cost-effectiveness analysis, if any, was done regarding the likely benefits of these costs, and what the results of that cost-effectiveness analysis was.

    Published: 28 April 2026

  6. Request received: 2 November 2025

    Please can you provide me with the follow up findings mentioned in the final report of DEFRA project VM02117 2001-2003 ‘Characterisation of non- acetylcholinesterase actions of OPs by identification of novel protein targets - VM02117’ ‘Contractor / Funded Organisations Medical Research Council’,

    1. as shown in the final report, namely the OP targets identified and their and relevance to human health - ‘Further work Assuming that there are no further hold ups, in the next six months the OP targets in the brain will be identified by mass spectrometric analysis and then fully characterised and their relevance to human health ascertained.’

    2. In addition, please can you advise what further work has been conducted in relation to this statement and provide me with the findings of any further studies:

    ‘Conclusions This study has confirmed our original hypothesis: that there are previously unrecognised proteins present in the brain that are adducted by organophosphates to which humans are currently exposed at dose levels which are low enough not to induce warning cholinergic signs. Furthermore, we have shown that, of the six organophosphates tested, each adducts a different spectrum of target proteins. Just one of them (chlorpyrifos) reacted only with the conventional target, acetylcholinesterase. This variability across structures has one important consequence: if the non-cholinesterase mediated actions of organophosphates are mediated by these proteins, then organophosphates must be assessed on a compound by compound basis - not as a homogenous class.’

    Internal review request received: 19 February 2026

    Published: 21 April 2026

  7. Request received: 14/03/2026

    I am writing to request information regarding the assessment and decision-making process for the Pre-clinical Translational Models Hub (MC_PC_2603), which is part of the government’s 2025/2026 "Replacing Animals in Science" funding commitment.

    To ensure transparency regarding the "experiential confidence" and potential institutional bias of the assessors, please provide:

    The names and host research organisations of all individuals appointed to the Assessment Panel (including the Chair and any "Introducing Members") for the MC_PC_2603 opportunity.

    The number of these panel members who currently hold a Home Office Project License (PPL) or act as the Establishment License Holder (PEL) at their respective institutions.

    Any Conflict of Interest declarations submitted by these panel members specifically relating to their institution’s reliance on animal-testing infrastructure or "Golden Triangle" collaborative frameworks.

    The criteria provided to the panel for weighing the "validation" of human-relevant models (NAMs) against legacy animal-based benchmarks, particularly where the assessors have a career history primarily based on in vivo research.

    Confirmation of whether any representatives from the NC3Rs or human-relevant technology biotechs are voting members of this specific panel.

    Published: 15 April 2026

  8. Request received: 14/03/2026

    I am writing to request information regarding the allocation and expenditure of the £60 million in new funding committed by the Department for Science, Innovation and Technology (DSIT) as part of the November 2025 strategy, “Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods.”

    Specifically, please provide:

    A breakdown of the £30 million allocated for the Preclinical Translational Models Hub. Please list any universities, private companies, or consortia that have been awarded funding or contracts to date to establish this hub.

    A breakdown of the £30 million allocated for the UK Centre for the Validation of Alternative Methods (UKCVAM). Please state the physical location(s) chosen for this centre and the lead institutions involved.

    The total number and value of "Validation Accelerator" grants awarded to date (2025–2026), including the names of the recipient institutions.

    A list of the Key Performance Indicators (KPIs) the department has established to monitor the "phase-out" progress, which the strategy committed to publishing in 2026.

    Confirmation of whether any of this £60m funding has been awarded to institutions that do not currently hold a Home Office Establishment License.

    Published: 15 April 2026

  9. Request received: 27 January 2026

    I’ve checked your previous information release database and I can’t find anything, but can you tell me whether an FOI request has already been made, for how much Innovate UK spends per annum on supporting disabled applicants apply for Innovate UK funding? I used keywords ‘Accessibility’ and ‘Access’ and ‘Access Support’.

    If not, can I please make a request for the following:

    • What the annual budget/expenditure is, for Innovate UK, to support disabled applicants to apply for Innovate UK funding, due to your online application process not being accessible to all.

    • Annual spend in 2024 or 2025.

    Published: 13 April 2026

  10. Request Received: 5 February 2026

    My request relates to the following contract award

    Please provide the following documents:

    a) All documents provided to potential bidders on this contract including

    • the proposed contract terms and

    • the scoring matrix to be used for bidders

    If the competition was run through a framework or a DPS please provide copies of both the call-off specification and the framework agreement that the competition was run under.

    b) The contract terms that were agreed with the winning supplier

    Published: 7 April 2026